Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0001213900-22-073502 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-17 | 2022-11-15+ | KTTA | Dumesnil Simon | Dir | A - Grant | $1.06 | +50.0K | 50.0K | New | +$53.1K |
| D | 2022-11-17 | 2021-08-02 | KTTA | Dumesnil Simon | Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-15 | A | A | 10,000 | $1.07 | 10,000 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-17 | A | A | 40,000 | $1.06 | 50,000 | D | — | — | |
| 3 | Derivative | Stock Option (to acquire Common Stock) | 2021-08-02 | A | A | 100,000 | $0.00 | 100,000 | D | $6.00 · 2022-08-02 to 2031-08-02 | 100,000 Common Stock | (F1) The Reporting Person was granted 100,000 stock options which have a ten-year term. The option is vested and exercisable with regard to 50,000 shares of Common Stock. The remaining 50% vest, subject to Mr. Dumesnil's remaining employed and in good standing, on August 2, 2023. |